Literature DB >> 16717443

Effects of midazolam and morphine on cerebral oxygenation and hemodynamics in ventilated premature infants.

A A E M van Alfen-van der Velden1, J C W Hopman, J H G M Klaessens, T Feuth, R C A Sengers, K D Liem.   

Abstract

BACKGROUND: Midazolam sedation and morphine analgesia are commonly used in ventilated premature infants.
OBJECTIVES: To evaluate the effects of midazolam versus morphine infusion on cerebral oxygenation and hemodynamics in ventilated premature infants.
METHODS: 11 patients (GA 26.6-33.0 weeks, BW 780-2,335 g) were sedated with midazolam (loading dose 0.2 mg/kg, maintenance 0.2 mg/kg/h) and 10 patients (GA 26.4-33.3 weeks, BW 842-1,955 g) were sedated with morphine (loading dose 0.05 mg/kg, maintenance 0.01 mg/kg/h). Changes in oxyhemoglobin (Delta cO2Hb) and deoxyhemoglobin (Delta cHHb) were assessed using near infrared spectrophotometry. Changes in cHbD (= Delta cO(2)Hb - Delta cHHb) reflect changes in cerebral blood oxygenation and changes in concentration of total hemoglobin (Delta ctHb = Delta cO2Hb + Delta cHHb) represent changes in cerebral blood volume (DeltaCBV). Changes in cerebral blood flow velocity (DeltaCBFV) were intermittently measured using Doppler ultrasound. Heart rate (HR), mean arterial blood pressure (MABP), arterial oxygen saturation (saO2) and transcutaneous measured pO2 (tcpO2) and pCO2 (tcpCO2) were continuously registered. Statistical analyses were carried out using linear mixed models to account for the longitudinal character study design.
RESULTS: Within 15 min after the loading dose of midazolam, a decrease in saO2, tcpO2 and cHbD was observed in 5/11 infants. In addition, a fall in MABP and CBFV was observed 15 min after midazolam administration. Immediately after morphine infusion a decrease in saO2, tcpO2 and cHbD was observed in 6/10 infants. Furthermore, morphine infusion resulted in a persistent increase in CBV.
CONCLUSIONS: Administration of midazolam and morphine in ventilated premature infants causes significant changes in cerebral oxygenation and hemodynamics, which might be harmful. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16717443     DOI: 10.1159/000093489

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  12 in total

Review 1.  Pharmacological therapy for analgesia and sedation in the newborn.

Authors:  K J S Anand; R W Hall
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-11       Impact factor: 5.747

Review 2.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

3.  Sedation and analgesia in mechanically ventilated preterm neonates: continue standard of care or experiment?

Authors:  Christopher McPherson
Journal:  J Pediatr Pharmacol Ther       Date:  2012-10

Review 4.  Cerebral near-infrared spectroscopy as a measure of nociceptive evoked activity in critically ill infants.

Authors:  Manon Ranger; Celeste C Johnston; Catherine Limperopoulos; Janet E Rennick; Adre J du Plessis
Journal:  Pain Res Manag       Date:  2011 Sep-Oct       Impact factor: 3.037

5.  Adult responses to an ischemic stroke in a rat model of neonatal stress and morphine treatment.

Authors:  Sarah L Hays; Olga A Valieva; Ronald J McPherson; Sandra E Juul; Christine A Gleason
Journal:  Int J Dev Neurosci       Date:  2012-09-28       Impact factor: 2.457

6.  Assessing pain in preterm infants in the neonatal intensive care unit: moving to a 'brain-oriented' approach.

Authors:  Liisa Holsti; Ruth E Grunau; Eilon Shany
Journal:  Pain Manag       Date:  2011-03-01

Review 7.  Neonatal pain control and neurologic effects of anesthetics and sedatives in preterm infants.

Authors:  Christopher McPherson; Ruth E Grunau
Journal:  Clin Perinatol       Date:  2013-12-17       Impact factor: 3.430

8.  Premedication practices for delivery room intubations in premature infants in France: Results from the EPIPAGE 2 cohort study.

Authors:  Elizabeth Walter-Nicolet; Emilie Courtois; Christophe Milesi; Pierre-Yves Ancel; Alain Beuchée; Pierre Tourneux; Valérie Benhammou; Ricardo Carbajal; Xavier Durrmeyer
Journal:  PLoS One       Date:  2019-04-10       Impact factor: 3.240

Review 9.  The role of systematic reviews in pharmacovigilance planning and Clinical Trials Authorisation application: example from the SLEEPS trial.

Authors:  Carrol Gamble; Andrew Wolf; Ian Sinha; Catherine Spowart; Paula Williamson
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

Review 10.  Clinical pharmacology of midazolam in neonates and children: effect of disease-a review.

Authors:  Gian Maria Pacifici
Journal:  Int J Pediatr       Date:  2014-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.